Article
MIR 29B mediates epigenetic mechanisms of HBG gene activation
19 Mar 2019
Abstract excerpt
Sickle cell disease (SCD) affects over 2 million people worldwide with high morbidity and mortality in underdeveloped countries. Therapeutic interventions aimed at reactivating fetal haemoglobin (HbF) is an effective approach for improving survival and ameliorating the clinical severity of SCD. A class of agents that inhibit DNA methyltransferase (DNMT) activity show promise as HbF inducers because off-target...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
